June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
A prospective, randomized clinical trial evaluating the effect of transcorneal electrical stimulation on visual function
Author Affiliations & Notes
  • Olivia Y Wang
    Sidney Kimmel Medical College, Philadelphia, Pennsylvania, United States
  • Ann P Murchison
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Lisa A Hark
    Sidney Kimmel Medical College, Philadelphia, Pennsylvania, United States
  • Benjamin T. Leiby
    Biostatistics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
  • Safa Siraj
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Sayali Kale
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Daniel Kim
    Sidney Kimmel Medical College, Philadelphia, Pennsylvania, United States
  • Kamal Shair
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Robert Sergott
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Mark Moster
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Larry Donoso
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Jurij R Bilyk
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Julia A Haller
    Research, Wills Eye Hospial, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Olivia Wang, None; Ann Murchison, None; Lisa Hark, None; Benjamin Leiby, None; Safa Siraj, None; Sayali Kale, None; Daniel Kim, None; Kamal Shair, None; Robert Sergott, None; Mark Moster, None; Larry Donoso, None; Jurij Bilyk, None; Julia Haller, None
  • Footnotes
    Support  Department of Defense Grant W81XWH-12-2-0097
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3852. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Olivia Y Wang, Ann P Murchison, Lisa A Hark, Benjamin T. Leiby, Safa Siraj, Sayali Kale, Daniel Kim, Kamal Shair, Robert Sergott, Mark Moster, Larry Donoso, Jurij R Bilyk, Julia A Haller; A prospective, randomized clinical trial evaluating the effect of transcorneal electrical stimulation on visual function. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3852.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Traumatic optic neuropathy (TON), non-arteritic anterior ischemic neuropathy (NAION), and optic neuritis associated with multiple sclerosis (MS) can lead to untreatable visual compromise. To improve visual outcomes for these populations, new therapies are needed. The purpose of this prospective, randomized, sham-controlled study is to investigate the technical feasibility and efficacy of transcorneal electrical stimulation (TES) to improve visual function in participants diagnosed with TON, NAION, and optic neuritis due to MS.

Methods : Eligible participants with visual acuity (VA) worse than 20/40 and with no other ophthalmic diseases were recruited from the Wills Eye Hospital Emergency Department and Neuro-Ophthalmology clinics and randomized into treatment or sham-treatment groups for TES. After baseline testing for visual function, quality of life, and cognitive function, participants received 30 minutes of treatment or sham-treatment per week for 6 weeks. Sham-treatment participants then received 6 weeks of treatment. Repeat visual function testing was performed 1-week, 3 months, and 6 months post-treatment. The primary outcome measure for this study was the mean change in LogMAR values for VA. This report describes the baseline data for those enrolled and evaluates rate of adverse events.

Results : A total of 96 participants enrolled in the study between 7/10/2013 and 9/9/2016 and baseline data are reported. Thirteen participants had TON, 69 had NAION, and 14 had optic neuritis associated with MS. Thirty-eight (39.6%) participants were female and the mean age was 58 years. The mean VA (LogMar) was 0.9 in the TON group, 1.2 in the NAION group, and 0.9 in the MS group. The mean National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) score was 62.5 in the TON group, 64.2 in the NAION group, and 66.9 in the MS group. Sixty-four (67%) were assigned to the TES treatment group and 32 (33%) received the initial sham treatment. No participants experienced any adverse events associated with TES.

Conclusions : This abstract presents baseline data for a 4-year prospective sham-controlled clinical trial. Although enrolling TON participants was challenging, it is feasible to enroll participants with NAION and MS in this study and enrollment is complete. Results of visual function improvement after TES are under analysis and will be reported in the future.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×